Ethics in henrietta lacks
But does the cause justify the means?
HT: What can researchers or medical professionals take away from this story? The afterword of this book is an especially interesting read, as it includes the opinions of current i. Beauchamp, T. Gey never informed Henrietta that her tumor was being used for research.
Almost all of the forms deal with specimen retention to some degree, asking if the individual gives permission for the lab to use the specimen to better understand some aspect of genetic science or assist with variant reclassification. One of the most challenging aspects of my role is to be sure that patients understand the forms they sign prior to submitting a sample for genetic testing.
Beneficence henrietta lacks
You can step outside your own view and understand the issues in a more robust way. Patients are generally scheduled every 90 minutes, but it takes that much face-to-face time just to gather enough information, calculate risks, discuss potential testing and management options, and—most importantly—provide enough information that patients and families can make an informed decision about genetic testing and the implications for their individual situation. Thus, if Henrietta Lacks were a patient in the United States today, biospecimens collected solely for her clinical care would not require her consent for use in research. At the age of 31 she died of cervical cancer and her cancer cells were taken without her consent. If all these feels too far away from home, check the Alder Hey scandal. Some of the real significant issues in this case relate to a lack of respect for Ms. But as summarized below, these publications do not necessarily suggest consensus. Not everyone has the same attitude about medical records. The book encourages the reader to think about the dark history of experimentation on African Americans, the birth of bioethics, and the legal battles over who owns and controls genetic material. Survey participants responded to a scenario specifically about a proposed biobank at the University of Iowa that would store residual clinical samples that would otherwise be discarded.
But the rules have changed since then, and they are still changing. They deserved that information and the opportunity to make an informed decision.
based on 48 review